Rallybio RLYB
NASDAQ RLYB
$15.80 +0.04 (+0.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Rallybio (RLYB) Non Operating Interest Expenses (2020 - 2021)

Updated

Rallybio (RLYB) recorded Non Operating Interest Expenses of $10,000 in FY2021, down 79.6% from $49,000 in FY2020.

Analysis

Rallybio (RLYB) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

  • Per Business Quant data, RLYB's Non Operating Interest Expenses was $49,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Rallybio 84.05 Mn -201.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 10,000.00
Dec 31, 2020 12,000.00
Sep 30, 2020 13,000.00
Jun 30, 2020 12,000.00
API Access

Rallybio Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RLYB&period=max&api_key=YOUR_API_KEY